081sek
5,2 %
Date:2025-05-12Time:17:07:30Latest report:Q4-2024List:First NorthTicker:SPEC
Market Cap:78 msekEnterprise Value:65 msekNet Sales:- msekEarnings:−23,0 msekEmployees:0ISIN:SE0007158118

Ratios

10-year key figure history for SpectraCure turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for SpectraCure with index and moving average MA50 and MA200.

Stockprice:0,81
MA50:1,65
MA200:2,04
Price/MA200:−60,8 %
RSI (14):24,2
Price/MA50:−51,6 %

Description

SpectraCure AB develops treatment planning and laser light dose management for cancer treatment. The Company has developed its software IDOSE, and medical laser devices for the treatment.

Medical Equipment